| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.0056 | 0.9 |